: An agreement to provide DNA-based diagnostic service to the public at lower cost and to develop newer diagnostic methods has been signed here.
The memorandum of understanding was signed between CSIR-Centre for Cellular and Molecular Biology (CCMB), andCentre for DNA Fingerprinting and Diagnostics (CDFD), an official press release said Wednesday.
The objectives of the MoU include provision of quality DNA-based diagnostic services to the public at lower costs, to develop newer diagnostic methods and to engage in scientific research to improve understanding of human genetic disorders, the release said.
Both the institutes have also mutually agreed to undertake training and educational activities in genetic diagnostics, it said.
Most of the genetic disorders are presently untreatable and for those which can be treated, the treatment is very expensive, the release said.
The only option to address the problem is the preventive approach which requires prenatal diagnosis and genetic counselling, it said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
